Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fady Shehata

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Fertility and Sterility|January 15, 2011
A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriageBaris Ata, Seang Lin Tan, Fady Shehata, et al.
Human Reproduction (Oxford, England)|May 24, 2012
Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapyMausumi Das, Fady Shehata, Weon-Young Son, et al.
Fertility and Sterility|September 28, 2010
Age-related normogram for antral follicle count: McGill reference guideBenny Almog, Fady Shehata, Einat Shalom-Paz, et al.
Female Pelvic Medicine & Reconstructive Surgery|June 25, 2019
Outcomes of an Overnight-Stay Unit for Urogynecologic Surgery: Feasibility and Risk Factors for Failure of Next-Day DischargeAisling A Clancy, Julius Ilin, Dante Pascali, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 10, 2013
A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysisMichael H Dahan, Mohammed Agdi, Fady Shehata, et al.
Fertility and Sterility|May 18, 2011
Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancyMausumi Das, Fady Shehata, Anwar Moria, et al.
Fertility and Sterility|January 18, 2011
Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatmentAnwar Moria, Mausumi Das, Fady Shehata, et al.
Journal of Telemedicine and Telecare|August 1, 2019
Pathology perspective on gynaecologic malignancy screening questions in electronic consultationCarol Wang, Clare Liddy, Amir Afkham, et al.
Fertility and Sterility|March 30, 2011
Effects of ovarian endometrioma on embryo qualityShauna L Reinblatt, Levin Ishai, Fady Shehata, et al.
Fertility and Sterility|March 2, 2010
Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilizationBenny Almog, Boaz Sheizaf, Einat Shalom-Paz, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Fertility and Sterility|January 15, 2011
A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriageBaris Ata, Seang Lin Tan, Fady Shehata, et al.
Human Reproduction (Oxford, England)|May 24, 2012
Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapyMausumi Das, Fady Shehata, Weon-Young Son, et al.
Fertility and Sterility|September 28, 2010
Age-related normogram for antral follicle count: McGill reference guideBenny Almog, Fady Shehata, Einat Shalom-Paz, et al.
Female Pelvic Medicine & Reconstructive Surgery|June 25, 2019
Outcomes of an Overnight-Stay Unit for Urogynecologic Surgery: Feasibility and Risk Factors for Failure of Next-Day DischargeAisling A Clancy, Julius Ilin, Dante Pascali, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 10, 2013
A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysisMichael H Dahan, Mohammed Agdi, Fady Shehata, et al.
Fertility and Sterility|May 18, 2011
Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancyMausumi Das, Fady Shehata, Anwar Moria, et al.
Fertility and Sterility|January 18, 2011
Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatmentAnwar Moria, Mausumi Das, Fady Shehata, et al.
Journal of Telemedicine and Telecare|August 1, 2019
Pathology perspective on gynaecologic malignancy screening questions in electronic consultationCarol Wang, Clare Liddy, Amir Afkham, et al.
Fertility and Sterility|March 30, 2011
Effects of ovarian endometrioma on embryo qualityShauna L Reinblatt, Levin Ishai, Fady Shehata, et al.
Fertility and Sterility|March 2, 2010
Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilizationBenny Almog, Boaz Sheizaf, Einat Shalom-Paz, et al.
Pageof 3